Levopraz 10mg/75mg Capsule is a combination pharmaceutical formulation containing Dexrabeprazole 10mg and Levosulpiride 75mg, designed for the management of gastrointestinal disorders. Dexrabeprazole, a proton pump inhibitor, effectively suppresses gastric acid secretion by inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby providing symptomatic relief and promoting healing in acid-related conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and erosive esophagitis. Levosulpiride, a selective dopamine D2 receptor antagonist with prokinetic properties, enhances gastrointestinal motility and accelerates gastric emptying, which aids in alleviating symptoms of dyspepsia, gastroparesis, and functional dyspepsia. The synergistic effect of these two active ingredients addresses both acid suppression and motility enhancement, offering comprehensive management of upper gastrointestinal symptoms including heartburn, bloating, nausea, and epigastric discomfort. Levopraz is indicated for patients requiring combined acid inhibition and prokinetic therapy under medical supervision. Caution is advised in patients with hypersensitivity to components, and it should be used with consideration of potential drug interactions. Dosage and duration of treatment should be individualized based on clinical response and physician guidance.